Tempest Therapeutics Inc.

TPST | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.89

+$0.12 (+15.02%)

Sep 22, 2026, 2:31 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $12.36M

Enterprise Value $19.15M

Beta -1.66

Average Volume 187.98K

Shares Outstanding (Diluted) 15.22M

Shares Change YoY 300.32%

Institutional Ownership 4.73%

Exchange NASDAQ

ISIN US87978U2078

Price Performance

Price Change 1M -25.2%

Price Change 3M -38.4%

Price Change 6M -55.8%

Price Change YTD -73.9%

Price Change 1Y -91.8%

Price Change 3Y -84.7%

Price Change 5Y -99.6%

1M CAGR (ann.) -15.6%

1Y CAGR (ann.) -92.3%

5Y CAGR (ann.) -66.8%

All-Time CAGR -52.3%

Valuation

PE Ratio -0.17

Forward PE N/A

PEG Ratio -0.01

Forward PEG 0.02

PS Ratio N/A

Forward PS 0.20

PB Ratio -11.34

P/FCF Ratio -0.60

P/Adj. FCF Ratio -0.58

P/OCF Ratio -0.57

EV/Sales N/A

EV/EBIT -0.54

EV/EBITDA -0.48

EV/FCF -0.92

Earnings Yield -581.8%

FCF Yield -167.7%

Adj. FCF Yield -173.7%

Financial Health

Net Debt $6.78M

Total Debt $7.56M

Cash & Short-Term Investments $779K

Total Assets $9.63M

Current Ratio 0.38

Quick Ratio 0.38

Debt / Equity Ratio -6.94

Debt / EBITDA -0.19

Debt / FCF -0.36

OCF / Debt -2.74

Interest Coverage -1,767.09

Altman Z-Score -51.73

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -3.6%

Returns

Return on Assets -420.1%

Return on Equity -1270.1%

Return on Invested Capital -628.2%

Return on Capital Employed -784.2%

Return on Tangible Assets -420.1%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -33.7%

EPS CAGR 3Y -35.2%

EPS CAGR 5Y -9.6%

EPS CAGR 10Y 45.1%

FCF CAGR 3Y 9.1%

FCF CAGR 5Y 7.8%

FCF CAGR 10Y 6.1%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y 1.9%

Revenue Growth Next 3Y N/A

Earnings Date Nov 3, 2026

EPS Estimate (next Q) -$0.35

EPS Growth Est (next Q) -55.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $11

Price Target Upside 1328.6%

Cash Flow

Operating Cash Flow $-20.73M

Free Cash Flow $-20.73M

Adj. Free Cash Flow $-21.48M

FCF Per Share -$1.36

OCF Per Share -$1.36

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-22.18M

Operating Income $-40.64M

EBITDA $-40.29M

Net Income $-40.47M

EPS (Diluted) -$4.48

Revenue / Employee N/A

Profit / Employee $-10.12M

Employees 4